Genomic Instability - 20 Studies Found Status Study Not yet recruiting Study Name: Combination Chemotherapy With or Without Atezolizumab in Treating Patients With Stage III Colon Cancer and Deficient DNA Mismatch Repair or Microsatellite Instability Condition: Colon Adenocarcinoma DNA Repair Disorder Lynch Syndrome Date: 2016-09-22 Interventions: Drug: Atezolizumab Given IV Recruiting Study Name: A Phase II Study of Tegafur-Uracil as Maintenance Chemotherapy in Patients With Stage II of Colon Cancer Condition: MSI-L/MSS Stage II Colon Cancer Date: 2016-08-01 Interventions: Drug: tegafur-uracil Recruiting Study Name: A Study of Anti-PD-L1 Checkpoint Antibody (LY3300054) Alone and in Combination in Participants With Advanced Refractory Solid Tumors Condition: Solid Tumor Microsatellite Instability-High (MSI-H) Solid Tumors Drug: LY3300054 Administered I Recruiting Study Name: Study of Pembrolizumab (MK-3475) vs Standard Therapy in Participants With Microsatellite Instability-High (MSI-H) or Mismatch Repair Deficient (dMMR) Stage IV Colorectal Carcinoma (MK-3475-177/KEYNOTE-177) Condition: Colorectal Carcinoma Date: 2015-09-28 Interventions: Drug: mFOLFOX6 Regimen consist Active, not recruiting Study Name: Study of Pembrolizumab (MK-3475) as Monotherapy in Participants With Previously-Treated Locally Advanced Unresectable or Metastatic Colorectal Cancer (MK-3475-164/KEYNOTE-164) Condition: Colorectal Carcinoma Date: 2015-05-29 Interventions: Biological: Pembrolizumab IV infusion Other Names: Recruiting Study Name: A Phase 1/2 Study Exploring the Safety, Tolerability, and Efficacy of Pembrolizumab (MK-3475) in Combination With Epacadostat (INCB024360) in Subjects With Selected Cancers (INCB 24360-202 / MK-3475-037 / KEYNOTE-037/ ECHO-202) Condition: Malignant Solid Tumor Lymphoma, Large B-Cell, Diffuse Carc Date: 2014-06-26 Interventions: Drug: MK-3475 IV infusion Completed Study Name: Molecular Biology of Anal Cancer in HIV-Positive Patients Condition: Carcinoma HIV Infections Date: 2009-08-03 Completed Study Name: Efficacy and Safety of Olaparib in Pretreated Patients With Measurable Colorectal Cancer, Stratified by Microsatellite Instability (MSI) Status Condition: Colorectal Cancer Date: 2009-05-28 Interventions: Drug: olaparib 400 mg po bid continuously Completed Study Name: Genetic Study of Young Patients With Colorectal Cancer Condition: Colorectal Cancer Date: 2002-09-06 Interventions: Genetic: microsatellite instability analysis Recruiting Study Name: Deciphering Antitumour Response and Resistance With INtratumour Heterogeneity Condition: Non-small Cell Lung Cancer Date: 2014-12-05 Interventions: Drug: MPDL3280A Intravenous (I <<< Previous